New surgery targets hidden cancer in ovarian patients

NCT ID NCT05236686

Recruiting now Disease control Sponsor: Shanghai Gynecologic Oncology Group Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a surgery called hepato-celiac lymphadenectomy for people with advanced or recurrent ovarian cancer. The surgery removes lymph nodes near the liver and stomach that may contain cancer. The goal is to see if this extra step, along with standard tumor removal, helps keep the cancer from coming back for at least two years. About 94 participants will be enrolled.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Hepato-celiac lymphadenectomy (surgery to remove lymph nodes near the liver and stomach)
What this could lead to: If this surgery works well, it could become a standard part of treatment to help control advanced ovarian cancer and delay its return.
What could go wrong: This is a small, early-phase study (94 people) with no comparison group, so results may not be definitive. Surgery carries risks like infection, bleeding, and damage to nearby organs.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EPITHELIAL OVARIAN CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Carcinoma, Ovarian Epithelial fallopian tube cancer fallopian tube neoplasm Lymphatic Metastasis ovarian cancer ovarian carcinoma primary peritoneal carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

EPITHELIAL OVARIAN CANCER FALLOPIAN TUBE CANCER PRIMARY PERITONEAL CARCINOMA

Contacts and locations

Locations

Zhongshan Hospital, Fudan University
RECRUITING

Shanghai, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.